Tricarico M, Rinaldi M, Bonmassar E, Fuggetta M P, Barrera G, Fazio V M
Istituto Medicina Sperimentale, CNR, Area di Ricerca Tor Vergata, Rome, Italy.
Anticancer Res. 1999 Nov-Dec;19(6B):5149-54.
Lipid peroxidation of cell membrane yields a variety of final products whose a quantitatively important component is 4-hydroxynonenal (HNE). Previous studies performed in our laboratory suggest that HNE may play a physiological role in the control of cellular proliferation and/or differentiation. This appears to be further supported by our recent findings showing that pre-treatment of K562 cells with a physiological concentration of HNE leads to a marked reduction of susceptibility of NK cells. The observed regulatory effects of HNE on tumor cell growth and susceptibility to natural immune resistance, led us to try to better understand the immunotoxicological properties of this aldehyde. The present study analyses the effects of HNE on NK-mediated cytotoxicity. Treatment of MNC as effector cells with concentrations of HNE ranging from 0.001 to 1 microM for 1 h, did not produce noticeable effects on NK activity. Therefore, this aldehyde at physiological concentrations is able to differentiate tumor cells and to down-regulate target susceptibility to NK effectors from one side. On the other side, it is not able to modify the efficiency of the NK function. Moreover, HNE concentrations higher than 1 microM showed significant and concentration-dependent inhibition of NK activity. However, this effect is reversible and can be antagonized, at least in part, by treatment of effector cells with HNE in combination with beta-interferon.
细胞膜的脂质过氧化产生多种终产物,其中在数量上起重要作用的成分是4-羟基壬烯醛(HNE)。我们实验室之前进行的研究表明,HNE可能在细胞增殖和/或分化的调控中发挥生理作用。我们最近的研究结果显示,用生理浓度的HNE预处理K562细胞会导致NK细胞的敏感性显著降低,这似乎进一步支持了这一观点。观察到的HNE对肿瘤细胞生长和对天然免疫抵抗敏感性的调节作用,促使我们试图更好地了解这种醛的免疫毒理学特性。本研究分析了HNE对NK介导的细胞毒性的影响。用浓度范围为0.001至1 microM的HNE处理作为效应细胞的单核细胞1小时,对NK活性没有产生明显影响。因此,这种生理浓度的醛一方面能够区分肿瘤细胞并下调靶细胞对NK效应细胞的敏感性。另一方面,它不能改变NK功能的效率。此外,高于1 microM的HNE浓度显示出对NK活性的显著且浓度依赖性抑制。然而,这种效应是可逆的,并且至少部分地可以通过用HNE与β-干扰素联合处理效应细胞来拮抗。